There are recognized regional inequities in the availability of veterinary medicines for both companion and food production animals globally, and this results in differing abilities of the animal health sector to provide appropriate animal care – both preventatively and therapeutically – and negatively impacts on animal welfare.
Regardless of region and/or country, the regulatory approval processes all have similar outcomes objectives. Despite this common goal, the approval process is duplicated in various regions and/or countries, often requiring duplication of data generation even when the data already exists and has been demonstrated to be scientifically sound.
Regulatory convergence & harmonization between regions and/or countries should be explored and enacted where and if this would not undermine safe and effective veterinary medicines use.
